AHL Partners’s NeoGenomics NEO Stock Holding History

AHL Partners’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,231	Closed	-$125K	–	1326
2017 Q3	$125K	Buy	+11,231	New	+$109K	﹤0.01%	1219

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

AHL Partners's NEO Position: Q4 2017 in Review

AHL Partners sold out of NeoGenomics (NEO) in Q4 2017, closing a stake of 11,231 shares — an estimated $125K sold.

AHL Partners first reported a position in NEO in Q3 2017 and held it in 1 quarter. The position peaked at $125K in Q3 2017. 132 funds tracked by Wall St. Rank hold NEO as of Q4 2017.

AHL Partners reported no remaining NeoGenomics position as of Q4 2017 after selling out during the quarter.
AHL Partners sold 11,231 NeoGenomics shares in Q4 2017, an estimated $125K.
AHL Partners first reported a position in NeoGenomics in Q3 2017 and held it in 1 quarter.
AHL Partners's NeoGenomics position peaked at $125K in Q3 2017.
132 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.